Your session is about to expire
← Back to Search
Nutrition and Exercise for Pulmonary Arterial Hypertension
Study Summary
This trial will test whether diet and exercise can help improve Pulmonary Arterial Hypertension by affecting insulin sensitivity.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have high blood pressure in my lungs caused by lung disease and low oxygen levels.I need more than 4 liters per minute of oxygen.I have high blood pressure in my lungs due to a blood disorder or sarcoidosis.My heart cannot pump blood properly on the right side.You have signs of heart problems during a stress test.I have Group 1 PAH, which may be related to a genetic condition, drug use, or another disease.My diuretic dose and oxygen support have been stable for the last 2 months.I have Type 2 Diabetes.I have high blood pressure in my lungs caused by heart disease.You have fainted in the last 3 months.I have been diagnosed with chronic blood clot-related lung high blood pressure.I do not have heart rhythm problems, except for controlled atrial fibrillation or flutter.You have severe heart failure.My heart condition mildly or moderately affects my daily activities.I am between 18 and 75 years old.I have high blood pressure in the veins of my liver.I have been on a stable dose of PAH treatment for at least 2 months.
- Group 1: Nutrition and Exercise
- Group 2: Standard of Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is eligibility for this research limited to adults aged 18 and over?
"This study seeks to enroll individuals aged 18 or older but not exceeding the age of 75."
Do I qualify for participation in this investigation?
"This clinical trial is seeking around 34 participants who are aged 18 to 75 and suffer from pulmonary arterial hypertension."
Are there any opportunities currently available to join this scientific research?
"The clinical trial's corresponding listing on the government-managed website clinicaltrials.gov reveals that this research initiative is not actively recruiting patients at present; it was first posted on September 27th 2017 and last edited back in May 6th 2022. Despite this, there are presently 907 other studies requiring participants."
Share this study with friends
Copy Link
Messenger